Nexavar
sorafenib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Bayer HealthCare Pharmaceuticals Inc.
sorafenib
Listed by Upsher-Smith Laboratories, LLC
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Sorafenib 200 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 24979-715 |
| FDA application | ANDA209050 |
| RxNorm concept | 597747 |
| Package sizes listed | 2 |
| Marketed since | December 2022 |
Other products containing Sorafenib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Nexavar
sorafenib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Bayer HealthCare Pharmaceuticals Inc.
Sorafenib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Torrent Pharmaceuticals Limited
sorafenib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Golden State Medical Supply, Inc.
sorafenib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Yabao Pharmaceutical Co., Ltd. Beijing
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.